๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Recurrent Liver Cancer

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation? NCT06777017n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment NCT06537193NA1 site๐Ÿ“ Seoul Asan Medical Center ยท Tests: AMRI, CT Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site๐Ÿ“ Nanjing Nanjing Medical University Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance NCT06653062n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Plasma and Tumor Tissue Mitochondrial DNA (mtDNA) Mutation Analysis Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence NCT07839767n/a1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Liver-in-cube testing A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors NCT07337460Phase 21 site๐Ÿ“ Yangzhou Northern Jiangsu People's Hospital ยท Tests: Icaritin Soft Capsules and mFOLFOX ๏ผšOxaliplatin,leucovorin calcium,5-fluorouracil Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors NCT04803318Phase 21 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Combination of three inhibitors Trametinib, Everolimus and Lenvatinib Cabozantinib to Treat Recurrent Liver Cancer Post Transplant NCT04204850Phase 21 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Cabozantinib Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer NCT05323201Phase 1, Phase 21 site๐Ÿ“ Xuzhou The Affiliated Hospital of Xuzhou Medical University ยท Tests: fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer NCT06532799Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine, Interleukin-2, Pembrolizumab The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma NCT06609850NA1 site๐Ÿ“ Beijing Sun Yat-sen University ยท Tests: TACE, Ablation, Lenvatinb Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. NCT05862337Phase 367 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Hefei Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab โ€ฆ Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Tissue Collection HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma NCT04499833NA1 site๐Ÿ“ Lisbon Centro Hospitalar de Lisboa Central ยท Tests: liver transplant Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme NCT06475352Phase 241 sites๐Ÿ“ Amiens๐Ÿ“ Aurillac๐Ÿ“ Avignon UNICANCER ยท Tests: FOLFOX regimen, CAPOX regimen Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC NCT05596630NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Stereotactic body radiation therapy Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model NCT06420440Phase 22 sites๐Ÿ“ Xiangyang๐Ÿ“ Jinan Chen Xiaoping ยท Tests: Hepatic arterial infusion chemotherapy, Lenvatinib, Tislelizumab, Liver resection, Tislelizumab Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer NCT06934018NA1 site๐Ÿ“ Shanghai Fudan University ยท Tests: Surgery and procedure, Surgery and procedure Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA NCT05375370NA1 site๐Ÿ“ Rouen University Hospital, Rouen ยท Tests: circulating tumor DNA dosage Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence NCT06644937Phase 2, Phase 31 site๐Ÿ“ Guangzhou Zhujiang Hospital ยท Tests: TACE combined with Acoradine Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC NCT05733598Phase 212 sites๐Ÿ“ Beverly Hills๐Ÿ“ La Jolla๐Ÿ“ Miami Replimune, Inc. ยท Tests: RP2, Bevacizumab, Atezolizumab, Durvalumab, RP2 Monotherapy Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma NCT07014150Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Lenvatinib, Iparomlimab and Tuvonralimab A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors NCT05150691Phase 1, Phase 2102 sites๐Ÿ“ Cerritos๐Ÿ“ Los Angeles๐Ÿ“ San Diego DualityBio Inc. ยท Tests: DB-1303/BNT323, Pertuzumab Injection, Ritonavir, Itraconazole Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection NCT06454578Phase 21 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Adebrelimab + Apatinib Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Biospecimen Collection, Immune Checkpoint Inhibitor Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma NCT06327269EARLY Phase 11 site๐Ÿ“ Kaohsiung City Chang Gung Memorial Hospital ยท Tests: Lenvatinib 10 mg
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy